Back
Nuveen Real Asset Income and Growth Fund Vs. Korro Bio Industry Stock Comparison
Buy
66
JRI
Nuveen Real Asset Income and Growth Fund
Last Price:
13.18
Seasonality Move:
1.16%
Sell
35
KRRO
Korro Bio
Last Price:
50.13
Seasonality Move:
51.42%
Buy
66
Nuveen Real Asset Income and Growth Fund (JRI)
is a Buy
Is Nuveen Real Asset Income and Growth Fund a Buy, Sell or Hold?
- The current Nuveen Real Asset Income and Growth Fund [JRI] share price is $13.21. The Score for JRI is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- JRI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Korro Bio (KRRO)
is a Sell
Is Korro Bio a Buy, Sell or Hold?
- The current Korro Bio [KRRO] share price is $49.70. The Score for KRRO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- KRRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JRI Stock Price Chart
What is Nuveen Real Asset Income and Growth Fund's stock price today?
-
The Nuveen Real Asset Income and Growth Fund share price today is $13.21
The current trend is moderately bearish and JRI is experiencing slight selling pressure.
JRI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 49.84 | Sell |
| Chaikin Money Flow: | -9353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.03 - 13.31) | Buy |
| Bollinger Bands (100): | (12.5 - 13.3) | Buy |
KRRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.47 | Buy |
| Relative Strength Index (14 RSI): | 40.22 | Sell |
| Chaikin Money Flow: | -97835 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.87 - 74.85) | Sell |
| Bollinger Bands (100): | (34.14 - 58.9) | Buy |
JRI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.33 | Sell |
| 20-day SMA: | 13.17 | Buy |
| 50-day SMA: | 13.24 | Sell |
| 200-day SMA: | 12.23 | Buy |
| 8-day EMA: | 13.27 | Sell |
| 20-day EMA: | 13.23 | Sell |
| 50-day EMA: | 13.14 | Buy |
| 200-day EMA: | 12.45 | Buy |
KRRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.46 | Sell |
| 20-day SMA: | 65.47 | Sell |
| 50-day SMA: | 49.92 | Sell |
| 200-day SMA: | 51.82 | Sell |
| 8-day EMA: | 61.13 | Sell |
| 20-day EMA: | 60.96 | Sell |
| 50-day EMA: | 54.54 | Sell |
| 200-day EMA: | 49.56 | Buy |
Nuveen Real Asset Income and Growth Fund Earnings Growth & JRI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Korro Bio Earnings Growth & KRRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.08 per share, and a decrease next year of $0.48 per share.
Nuveen Real Asset Income and Growth Fund Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Korro Bio Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||